Abstract #3051
Prospective Glioma Grading Using Single Dose Dynamic Contrast Enhanced MRI Perfusion
Aprajita Mehta 1 , Krishan K Jain 1 , Prativa Sahoo 2 , Bhaswati Roy 1 , Ritu Tyagi 1 , Ram K S Rathore 3 , Rana Patir 4 , Sandeep Vaishya 4 , Neeraj Prakash 5 , Nandini Vasudev 5 , and Rakesh K Gupta 1
1
Radiology, Fortis Memorial Research
Institute, Gurgaon, India,
2
Philips
Healthcare, Philips India Ltd, Gurgaon, India,
3
Dept
of Mathematics, Indian Institute of Technology, Kanpur,
India,
4
Neurosurgery,
Fortis Memorial Research Institute, Gurgaon, India,
5
Pathology,
Fortis Memorial Research Institute, Gurgaon, India
It is important to differentiate high and low grade
gliomas as treatment strategies are different for
different grade of gliomas. Prospective grading of
gliomas is helpful in explaining the prognosis to
patient and where surgery or biopsy of tumor is
difficult, clinical decision may be taken on the basis
of perfusion imaging. We planned this study to evaluate
the relative sensitivity and specificity of Dynamic
Contrast Enhanced MR perfusion with single dose contrast
in prospective evaluation of glioma grading. Without
additional dose of contrast, perfusion study could be
added to the routine brain tumor imaging protocol in
differentiating the grade of gliomas.
This abstract and the presentation materials are available to members only;
a login is required.
Join Here
